[Retracted] Pan-Cancer Analysis of Prognostic and Immune Infiltrates for the TMEM65, Especially for the Breast Cancer

Figure 1

(a) The expression of TMEM65 in 33 different tumor cell lines. (b) TMEM65 was correlated with the clinical stage for the BLCA. (c)TMEM65 was correlated with the clinical stage for the KIRC, (d) TMEM65 was correlated with the clinical stage for the LUSC, (e) TMEM65 was correlated with the clinical stage for the READ, and (f) TMEM65 was correlated with the clinical stage for the THCA.TMEM65, which was correlated with the OS in six kinds of tumors, comprised of BRCA, LIHC, SARC, STAD, and UCEC (g–h) (i) The link between the TMEM65 and kinds of tumor types for PFI on forest plot. The KM curve was explored for the PFI (m–o).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)